About the review
The MRAC is conducting a review of long-acting reversible contraceptives (LARC).
In June 2024, the Minister for Health and Aged Care, requested the MRAC undertake a phased review of MBS items for the insertion and removal of long-acting reversible contraceptives as part of the Government’s commitment to improving women’s health outcomes.
A working group was established to lead this review and report back to the full committee on its findings.
Who we work with
The Long-Acting Reversible Contraceptives (LARC) working group members lead this review and report back to the full committee on its findings.
Member | Area of specialty or expertise |
---|---|
Professor Sally Green (Chair) | Health systems |
Ms Jan Donovan | Consumer Representative |
Conjoint Professor Anne Duggan (MRAC Chair) | Gastroenterologist |
Adjunct Associate Professor Chris Helms | Nurse Practitioner |
Associate Professor Elizabeth Marles | General Practice / Indigenous Health and Health Policy |
Dr Sue Masel | Rural General Practice |
Professor Rosalie Viney | Health Economist |
Departmental Medical Adviser | |
Associate Professor Andrew Singer | Principal Medical Adviser, Department of Health |
Why the review is important
A review of LARC MBS items will support the Government’s ongoing commitment to improve health outcomes for women and girls in Australia, including providing an opportunity for the Department of Health and Aged Care to consider how to more broadly support awareness and high-quality provision of these important services.
Status
A targeted stakeholder consultation workshop was held in mid-July regarding MBS items for long-acting reversible contraceptive (LARC) insertion and removal.
The LARC working group met in July 2024 and developed draft recommendations for phase one of the review to be considered by the MRAC.
The recommendations were endorsed by the MRAC at their August 2024. Initial advice will be provided to government for consideration.
The LARC Working Group are expected to meet in early 2025 to undertake the second phase of this review.
Further consultation processes are scheduled to occur for the initial and the secondary stages of this review.
Activities to date
Date | Activity |
---|---|
20 August 2024 | The MRAC endorsed the recommendations |
23 July 2024 | First meeting of LARC working group held |
16 July 2024 | Targeted stakeholder consultation workshop held |